Foresee Pharmaceuticals Co., Ltd. announced the appointment of Chris Liang as Accounting Officer. Name, title, and resume of the new position holder: Chris Liang /Accounting Associate Manager, Foresee /Associate Manager, KPMG Taiwan. Effective date is on May 03, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
84.1 TWD | -0.24% |
|
-0.24% | -12.58% |
Jun. 24 | Foresee Pharmaceuticals Co., Ltd. announced a financing transaction | CI |
May. 14 | Foresee Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.58% | 351M | |
+16.59% | 44.44B | |
+41.42% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals Co., Ltd. Appoints Chris Liang as Accounting Officer